Grufity logo
Grufity logo

Latest Blue Owl Capital Holdings LP Stock Portfolio

$664Million | No. of Holdings #71

Blue Owl Capital Holdings LP Performance

2026 Q2+6.67%
YTD+7.15%
2025-3.75%

About Blue Owl Capital Holdings LP and 13F Hedge Fund Stock Holdings

On 2026-08-11, the fund reported it's updated stock portfolio. In the 13F Holdings report, Blue Owl Capital Holdings LP reported an equity portfolio of $664.5 Millions as of 30 Jun, 2026. <br><br> The top stock holdings of Blue Owl Capital Holdings LP are , , CGEM. The fund has invested 36% of it's portfolio in SPACE EXPLORATION TECHN CORP and 14.9% of portfolio in AKTIS ONCOLOGY INC. <br><br> The fund managers got completely rid off ENGENE HOLDINGS INC, CIVEO CORP CDA (CVEO) and KALVISTA PHARMACEUTICALS INC (KALV) stocks. They significantly reduced their stock positions in ELEDON PHARMACEUTICALS INC (ELDN), CONTEXT THERAPEUTICS INC (CNTX) and ULTRAGENYX PHARMACEUTICAL IN (RARE). Blue Owl Capital Holdings LP opened new stock positions in SPACE EXPLORATION TECHN CORP, CAPITAL ONE FINL CORP (COF) and COMPASS PATHWAYS PLC (CMPS). The fund showed a lot of confidence in some stocks as they added substantially to SAGIMET BIOSCIENCES INC, ORIC PHARMACEUTICALS INC (ORIC) and DELL TECHNOLOGIES INC (DELL).
Blue Owl Capital Holdings LP Equity Portfolio Value
Last Reported on: 11 Aug, 2026
$664Million
  as of Aug 11, 2026

Blue Owl Capital Holdings LP Annual Return Estimates Vs S&P 500

Our best estimate is that Blue Owl Capital Holdings LP made a return of 6.67% in the last quarter. In trailing 12 months, it's portfolio return was 30.66%.
  • Performance
  • S&P 500

New Buys

Ticker$ Bought
space exploration techn corp 239,002,000
capital one finl corp 24,025,600
deep fission inc14,720,000
artiva biotherapeutics inc 8,483,060
compass pathways plc 6,367,500
viridian therapeutics inc4,776,200
cabaletta bio inc2,222,750
chime finl inc 1,840,700
New stocks bought by Blue Owl Capital Holdings LP

Additions

Ticker% Inc.
sagimet biosciences inc277
oric pharmaceuticals inc 166
dell technologies inc137
evommune inc 80.00
lenz therapeutics inc 49.34
larimar therapeutics inc28.7
starwood ppty tr inc 23.85
compass therapeutics inc23.2
Additions to existing portfolio by Blue Owl Capital Holdings LP

Reductions

Ticker% Reduced
eledon pharmaceuticals inc-60.1
context therapeutics inc -42.35
ultragenyx pharmaceutical in -39.65
aquestive therapeutics inc-30.05
maplight therapeutics inc-27.44
immix biopharma inc -20.09
cullinan therapeutics inc-19.37
eyepoint inc-16.44
Blue Owl Capital Holdings LP reduced stake in above stock

Sold off

Ticker$ Sold
engene holdings inc-30,075,400
pliant therapeutics inc -3,741,190
ovid therapeutics inc-4,228,360
syntec optics hldgs inc-867,383
cid holdco inc-94,751
engene holdings inc -1,293,280
katapult holdings inc0.00
alpha modus hldgs inc-145,809
Blue Owl Capital Holdings LP got rid off the above stocks

Sector Distribution

Blue Owl Capital Holdings LP has about 70.4% of it's holdings in Others sector.

  • Others
  • Healthcare
  • Financial Services
  • Technology
  • Consumer Cyclical
Sector%
Others70.4
Healthcare20.2
Financial Services3.7
Technology3.3
Consumer Cyclical1.9

Market Cap. Distribution

Blue Owl Capital Holdings LP has about 5.9% of it's portfolio invested in the large-cap and mega-cap stocks.

  • UNALLOCATED
  • SMALL-CAP
  • LARGE-CAP
  • MID-CAP
  • MICRO-CAP
  • MEGA-CAP
Category%
UNALLOCATED70.4
SMALL-CAP17.7
LARGE-CAP3.7
MID-CAP3.2
MICRO-CAP2.7
MEGA-CAP2.2

Stocks belong to which Index?

About 21.7% of the stocks held by Blue Owl Capital Holdings LP either belong to S&P 500 or RUSSELL 2000 index.

  • Others
  • RUSSELL 2000
  • S&P 500
Index%
Others78.3
RUSSELL 200018
S&P 5003.7
Top 5 Winners (%)%
DAVE
dave inc
781.4 %
tevogen bio hldgs inc
100.0 %
aktis oncology inc
79.0 %
DELL
dell technologies inc
78.7 %
maplight therapeutics inc
65.8 %
Top 5 Winners ($)$
aktis oncology inc
44.7 M
maplight therapeutics inc
13.5 M
CGEM
cullinan therapeutics inc
6.9 M
DELL
dell technologies inc
6.3 M
RARE
ultragenyx pharmaceutical in
3.0 M
Top 5 Losers (%)%
shf holdings inc
-71.1 %
ADCT
adc therapeutics sa
-69.7 %
EMLD
fold hldgs inc
-65.9 %
CNTX
context therapeutics inc
-62.2 %
CMPX
compass therapeutics inc
-56.2 %
Top 5 Losers ($)$
LRMR
larimar therapeutics inc
-11.8 M
CMPX
compass therapeutics inc
-10.2 M
CNTX
context therapeutics inc
-8.3 M
HLLY
holley inc
-2.2 M
lenz therapeutics inc
-2.2 M

Blue Owl Capital Holdings LP Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Blue Owl Capital Holdings LP

Blue Owl Capital Holdings LP has 71 stocks in it's portfolio. About 78.5% of the portfolio is in top 10 stocks. LRMR proved to be the most loss making stock for the portfolio. was the most profitable stock for Blue Owl Capital Holdings LP last quarter.

$658.00MTotal Value
86.00Positions
11 Aug, 2026Last Reported
Current holdings of Current Stock Holdings of Blue Owl Capital Holdings LP, last reported on 11 Aug, 2026. Select a row with a linked ticker to view its historical trend.
ExpandHoldingsorted ascending% PortfolioShares Held$ Value% Change
ADCT
Adc Therapeutics Sa

Adc Therapeutics Sa

ADCT
Blue Owl Capital Holdings LP's holding in Adc Therapeutics Sa over time
0.12%733,568
$784.9K
0.12%
unchanged 0 percentunchanged
CMPS
Compass Pathways Plc

Compass Pathways Plc

CMPS
Blue Owl Capital Holdings LP's holding in Compass Pathways Plc over time
0.96%450,000
$6.37M
0.96%
new position
CYBN
Cybin Inc

Cybin Inc

CYBN
Blue Owl Capital Holdings LP's holding in Cybin Inc over time
0.06%59,911
$396.0K
0.06%
new position
EMLD
Fold Hldgs Inc

Fold Hldgs Inc

EMLD
Blue Owl Capital Holdings LP's holding in Fold Hldgs Inc over time
0.06%856,632
$385.5K
0.06%
unchanged 0 percentunchanged